Effect of HIV Infection and Antiretroviral Therapy Duration on CD4 Count, Total and Differential White Cell Count
Journal Title: International STD Research & Reviews - Year 2015, Vol 3, Issue 1
Abstract
Aims: To assess CD4 counts, total and differential white cell counts in HIV positive patients on antiretroviral treatment (ART) and those not on antiretroviral treatments with varying durations of infection. Study Design: Case-control study. Place and Duration of Study: Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria from March to August 2013. Methodology: We included 181 subjects; sixty HIV patients on ART with infection duration of <1 – 5, >5 – 8 and >8 – 17 years and ART duration of <1 – 5, >5 – 8 and >8 – 17 years; sixty HIV patients not on ART with an infection duration of <1 – 3, >3 – 6 and >6 – 11years; and sixty-one apparently healthy individuals control. CD4 counts, total and differential white cell counts as well as Human Immunodeficiency virus (HIV) status were determined. Results: CD4 counts was significantly higher in the control compared to the ART and non-ART and lower in HIV duration of <1 – 3 years compared to >3 – 6 years and >6 – 11 years (P<0.05). TWBC was significantly higher in non-ART compared to ART and control (P<0.05). MXD was significantly lower in control compared to ART and non-ART (P<0.05). NEUT was significantly higher in non-ART than control while LYM was higher in non-ART than ART (P<.05). TWBC was lower in <1 -3 years than >6 – 11 years both in non-ART subjects (P<.05) TWBC was also higher in female controls than male (P<.05). Conclusion: CD4 count is generally lower in HIV subjects. TWBC is elevated in non-ART, while MXD is higher in ART and non-ART subjects. There is no difference in white cell parameters for ART subjects irrespective of differences in duration of HIV infection and antiretroviral therapy.
Authors and Affiliations
C. O. Okeke, G. I. Amilo, M. O. Ifeanyichukwu, E. O. Obi, A. C. Okeke, N. C. Ibeh
A Cost-effectiveness Study of the Quadrivalent HPV6/11/16/18 Vaccination in a Two-dose Scheme in Girls of 9-11 Years Old Compared to Bivalent HPV 16/18 Vaccination in Ecuador and Challenges for Public Health and Screening
Aims: Assess the incremental cost-effectiveness of the quadrivalent HPV6/11/16/18 vaccination as administered in a two-dose scheme to girls between 9 and 11 years old, as compared to the bivalent HPV 16/18 vaccination ad...
The Integration of HIV/AIDS and Non-communicable Disease Policies
Developing countries are currently facing a double burden of communicable diseases, like HIV/AIDS, and chronic non-communicable diseases (NCDs). As HIV/AIDS has already turned out to be a chronic disease, the approaches...
Burden of Gonorrhea and Trends in Antibiotic Susceptibility Pattern of Neisseria gonorrhoea in Bhutan Over Four Years (2012-15)
Introduction: Gonorrhea is a worldwide public health problem. In Bhutan, the incidence of sexually transmitted infections increased from 12/10,000 in 2011 to 92/10,000 population in 2015. Disease burden and antibiotic re...
Non-adherence to Highly Active Antiretroviral Therapy and Occurrence of Opportunistic Infections among Adult Clients Accessing Care at a Secondary Health Facility in Imo State Nigeria
Background: Non-adherence remains an issue of concern in highly active anti-retroviral therapy (HAART). It has been reported to reduce the immunological benefit of this regimen, while increasing morbidities and mortaliti...
Knowledge, Attitude and the Use of Patient Package Inserts: Perspectives on Adherence to Antiretroviral Therapy
Introduction: Patient package insert is an innovative tool capable of providing additional medication information in written form; it has the potential to promote adherence to antiretroviral medicines. Objectives: This s...